Downstream of Tyrosine Kinase 1 and 2 Play Opposing Roles in CD200 Receptor Signaling

被引:54
|
作者
Mihrshahi, Robin [1 ]
Brown, Marion H. [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
来源
JOURNAL OF IMMUNOLOGY | 2010年 / 185卷 / 12期
基金
英国医学研究理事会;
关键词
MACROPHAGE ACTIVATION; PROGNOSTIC-FACTOR; SURFACE-PROTEINS; DOWN-REGULATION; CELL; INHIBITION; FAMILY; MICE; CRKL; PHOSPHORYLATION;
D O I
10.4049/jimmunol.1002858
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CD200 receptor (CD200R) negatively regulates myeloid cells by interacting with its widely expressed ligand CD200. CD200R signals through a unique inhibitory pathway involving a direct interaction with the adaptor protein downstream of tyrosine kinase 2 (Dok2) and the subsequent recruitment and activation of Ras GTPase-activating protein (RasGAP). Ligand engagement of CD200R also results in tyrosine phosphorylation of Dok1, but this protein is not essential for inhibitory CD200R signaling in human myeloid cells. In this paper, we show that CD200R-induced phosphorylation of Dok2 precedes phosphorylation of Dok1, and that Dok2 and Dok1 recruit different downstream proteins. Compared with Dok2, Dok1 recruits substantially less RasGAP. In addition to binding RasGAP, Dok2 recruits the adaptor molecule Nck in response to ligand engagement of CD200R. CD200R-induced phosphorylation of Dok1 results in the recruitment of CT10 sarcoma oncogene cellular homologue-like (CrkL), whereas the closely related CT10 sarcoma oncogene cellular homologue interacts constitutively with Dok1. Knockdown of Dok1 or CrkL expression in U937 cells resulted in increased Dok2 phosphorylation and RasGAP recruitment to Dok2. These data are consistent with a model in which Dok1 negatively regulates Dok2-mediated CD200R signaling through the recruitment of CrkL. The Journal of Immunology, 2010, 185: 7216-7222.
引用
收藏
页码:7216 / 7222
页数:7
相关论文
共 50 条
  • [41] ROR1 and ROR2 play distinct and opposing roles in endometrial cancer
    Henry, C. E.
    Llamosas, E.
    Daniels, B.
    Coopes, A.
    Tang, K.
    Ford, C. E.
    GYNECOLOGIC ONCOLOGY, 2018, 148 (03) : 576 - 584
  • [42] Myc and Mammary Cancer: Myc is a Downstream Effector of the ErbB2 Receptor Tyrosine Kinase
    Nancy E. Hynes
    Heidi A. Lane
    Journal of Mammary Gland Biology and Neoplasia, 2001, 6 : 141 - 150
  • [43] Casein Kinase 2 Dependent Phosphorylation of Neprilysin Regulates Receptor Tyrosine Kinase Signaling to Akt
    Siepmann, Martin
    Kumar, Sathish
    Mayer, Guenter
    Walter, Jochen
    PLOS ONE, 2010, 5 (10):
  • [44] CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1
    Erin, Nuray
    Dilmac, Sayra
    Curry, Anna
    Duymus, Ozlem
    Tanriover, Gamze
    Prodeus, Aaron
    Gariepy, Jean
    Gorczynski, Reginald M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (01) : 103 - 114
  • [45] GRB2 AND SH-PTP2 - POTENTIALLY IMPORTANT ENDOTHELIAL SIGNALING MOLECULES DOWNSTREAM OF THE TEK/TIE2 RECEPTOR TYROSINE KINASE
    HUANG, LW
    TURCK, CW
    RAO, P
    PETERS, KG
    ONCOGENE, 1995, 11 (10) : 2097 - 2103
  • [46] A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways
    Mukherji, Mridul
    Brill, Laurence M.
    Ficarro, Scott B.
    Hampton, Garret M.
    Schultz, Peter G.
    BIOCHEMISTRY, 2006, 45 (51) : 15529 - 15540
  • [47] CCM2 Mediates Death Signaling by the TrkA Receptor Tyrosine Kinase
    Harel, Liraz
    Costa, Barbara
    Tcherpakov, Marianna
    Zapatka, Marc
    Oberthuer, Andre
    Hansford, Loen M.
    Vojvodic, Milijana
    Levy, Zehava
    Chen, Zhe-Yu
    Lee, Francis S.
    Avigad, Smadar
    Yaniv, Isaac
    Shi, Leming
    Eils, Roland
    Fischer, Matthias
    Brors, Benedikt
    Kaplan, David R.
    Fainzilber, Mike
    NEURON, 2009, 63 (05) : 585 - 591
  • [48] CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1
    Nuray Erin
    Sayra Dilmaç
    Anna Curry
    Özlem Duymuş
    Gamze Tanriover
    Aaron Prodeus
    Jean Gariepy
    Reginald M. Gorczynski
    Cancer Immunology, Immunotherapy, 2020, 69 : 103 - 114
  • [49] Activation of protein-tyrosine kinase Pyk2 is downstream of Syk in FcεRI signaling
    Okazaki, H
    Zhang, J
    Hamawy, MM
    Siraganian, RP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) : 32443 - 32447
  • [50] A comparative study of Pointed and Yan expression reveals new complexity to the transcriptional networks downstream of receptor tyrosine kinase signaling
    Lachance, Jean-Francois Boisclair
    Pelaez, Nicolas
    Cassidy, Justin J.
    Webber, Jemma L.
    Rebay, Ilaria
    Carthew, Richard W.
    DEVELOPMENTAL BIOLOGY, 2014, 385 (02) : 263 - 278